| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/05/2005 | US20050095693 Selected nucleotide sequences isolated from pathogenic strains of haemophilus influenzae |
| 05/05/2005 | US20050095682 Campylobacter polypeptides and methods of use |
| 05/05/2005 | US20050095673 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells |
| 05/05/2005 | US20050095652 Solid support comprising immobilized biopolymers for use as assay in monitoring receptor ligand interaction; drug screening; antibodiy sensitivity |
| 05/05/2005 | US20050095644 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using thereof |
| 05/05/2005 | US20050095641 Methods and materials for detecting genetic material |
| 05/05/2005 | US20050095640 Intergenic or intronic regions for use as calibration tools in gene expression analysis |
| 05/05/2005 | US20050095632 Dna encoding human binding protein; genomes; gene expression |
| 05/05/2005 | US20050095623 Reacting nucleic acids with magnesium/sodium bisulfite in presence of polyamine catalyst (guanidine) to create point mutations; kits |
| 05/05/2005 | US20050095622 Method for rapid identification of molecules with functional activity towards biomolecular targets |
| 05/05/2005 | US20050095615 Methods and compositions for detecting promoter activity and expressing fusion proteins |
| 05/05/2005 | US20050095610 Generating nucleotide sequences markers using 3' chain terminating nucleoside triphosphates; molecular weight markers/controls |
| 05/05/2005 | US20050095605 Photoactive planktonic protein with improved optical characteristic for use as reporter molecule in imaging systems |
| 05/05/2005 | US20050095604 Novel modulators of amyloid-beta production and uses thereof |
| 05/05/2005 | US20050095603 Nucleotide sequence probe for use as tool in detection of tritrichomonas foetus; veterinary medicine |
| 05/05/2005 | US20050095584 Method for determining early HCV seroconversion |
| 05/05/2005 | US20050095240 NaCT as a target for lifespan expansion and weight reduction |
| 05/05/2005 | US20050095237 Antibodies that kill P2Y10-expressing cells linked to diseases such as inflammatory disorders, autoimmune diseases, allergic reaction, organ and tissue rejection, and mast cell diseases; immunotherapy; use of vaccines; diagnosis |
| 05/04/2005 | EP1527176A2 Further novel forms of interfering rna molecules |
| 05/04/2005 | EP1527172A1 Method for nucleic acid extraction and nucleic acid purification |
| 05/04/2005 | EP1527164A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 05/04/2005 | EP1527160A2 Production of glycosylated macrolides in e. coli |
| 05/04/2005 | EP0672139B1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/04/2005 | EP0456706B1 Molecular methods of hybrid seed production |
| 05/04/2005 | CN1611509A Nucleic acid adaptor for specific identifying human cerebral acetylcholinesterase and its use |
| 05/04/2005 | CN1200104C Plant phosphorus hunger inducing transcription factor OsPTF1 |
| 05/04/2005 | CN1200103C Fowl castration recombinant gene vector |
| 05/04/2005 | CN1200102C Livestock castration vaccine gene and recombinant gene vector |
| 05/04/2005 | CN1200101C Universal farm animal castration vaccine gene and recombinant gene vector |
| 05/04/2005 | CN1199999C Human protein for promoting transform of 3T3 cell and its coding sequence |
| 05/04/2005 | CN1199998C Human protein with suppression to cance cell growth and its coding sequence |
| 05/04/2005 | CN1199997C New human protein having mouse NIH/3T3 cell conversion promoting function and its coding sequence |
| 05/04/2005 | CN1199996C New human protein having cancer cell growth in hibiting function and its coding sequence |
| 05/04/2005 | CN1199995C New Human protein having cancer inhibiting function and its coding sequence |
| 05/04/2005 | CN1199994C New human protein with cancer cell growth inhibiting function and its coding sequence |
| 05/03/2005 | US6887990 For improved yield/purification; comprises attachment to a substrate; genomics/diagnostics |
| 05/03/2005 | US6887986 For washing and/or dishwashing detergent/textile desizing/starch liquefactionl; acidic/high temperature stability |
| 05/03/2005 | US6887985 Using probes for the detection of preferential viral nucleotide sequences in sample; obtain nucleotide sequences, incubate with probes, detect viral nucleotide sequences |
| 05/03/2005 | US6887978 Vanilloid receptor |
| 05/03/2005 | US6887906 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 05/03/2005 | US6887858 Method of treating dry eye disease with purinergic receptor agonists |
| 05/03/2005 | US6887715 Methods and compositions for producing biopolymeric arrays |
| 05/03/2005 | US6887690 Compound for use as a diagnostic tool in nucleotide sequencing |
| 05/03/2005 | US6887674 Artery- and vein-specific proteins and uses therefor |
| 05/03/2005 | US6887673 Containing light chain and a heavy chain peptide; anticarcinogenic agent |
| 05/03/2005 | US6887665 Forming a surface comprising photosensitive compound or group, an autocatalytic compound or group, compound capable of introducing latency irradiating at least a part of surface to remove protective group |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 04/28/2005 | WO2005038427A2 Rapid identification of viruses of the upper respiratory tract infection including sars causing coronus viruses |
| 04/28/2005 | WO2005038370A2 Genetic markers for obesity |
| 04/28/2005 | WO2005038056A1 Combination therapy for the treatment of viral diseases |
| 04/28/2005 | WO2005038048A1 Apparatus and methods for detecting nucleic acid in biological samples |
| 04/28/2005 | WO2005038035A2 Methods for producing and using in vivo pseudotyped retroviruses |
| 04/28/2005 | WO2005038013A1 Artisense oligonucleotides optimized for kidney targeting |
| 04/28/2005 | WO2005038006A2 Chimeric metabotropic glutamate receptors and uses thereof |
| 04/28/2005 | WO2005038003A2 Compositions and methods for generation of positive and negative selection vectors |
| 04/28/2005 | WO2005038002A2 Site-specific incorporation of redox active amino acids into proteins |
| 04/28/2005 | WO2005038001A2 Improved transgenesis by sperm-mediated gene transfer |
| 04/28/2005 | WO2005037997A2 Competition assay for identifying modulators of quadruplex nucleic acids |
| 04/28/2005 | WO2005037993A2 Promoters functional in plant plastids |
| 04/28/2005 | WO2005037988A2 Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid |
| 04/28/2005 | WO2005037854A2 Immunogenic peptides |
| 04/28/2005 | WO2005037850A2 Solid phase methods for polynucleotide production |
| 04/28/2005 | WO2005037226A2 Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders |
| 04/28/2005 | WO2005037218A2 Lentiviral vector delivery of il-21 for treatment of cancer |
| 04/28/2005 | WO2005024039A3 Improved method for generating influenza viruses and vaccines |
| 04/28/2005 | WO2005014609A3 Method of producing a highly stereoregular phosphorus atom-modified nucleotide analogue |
| 04/28/2005 | WO2005010165A3 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/28/2005 | WO2005003371A3 Erk7 and erk8, novel diagnostic markers for cancer |
| 04/28/2005 | WO2005001113A3 Methods for detecting nucleic acid variations |
| 04/28/2005 | WO2005001062A3 Modified vectors for organelle transfection |
| 04/28/2005 | WO2004113511A3 Cell line and uses thereof |
| 04/28/2005 | WO2004112570A3 Detection of survivin in the biological fluids of cancer patients |
| 04/28/2005 | WO2004104167A3 A δ-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts |
| 04/28/2005 | WO2004099379A3 Use of jag2 expression in diagnosis of plasma cell disorders |
| 04/28/2005 | WO2004098492A3 Trans-golgi network-associated processes, methods and compositions related thereto |
| 04/28/2005 | WO2004052309A3 Modulation of stat 6 expression |
| 04/28/2005 | WO2004048524A3 Modulation of stat2 expression |
| 04/28/2005 | WO2004032839A3 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/28/2005 | WO2003100076A3 Pna probes, probe sets, method and kits pertaining to the determination of listeria |
| 04/28/2005 | WO2003087389A3 Biologic modulations with nanoparticles |
| 04/28/2005 | WO2003072067A3 Compositions and methods for treating epithelial and retinal tissue diseases |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | WO2002092768A3 Novel alanine transaminase enzyme and methods of use |
| 04/28/2005 | US20050090646 cytotoxic fusion proteins that are useful for selectively killing endothelial cells in blood vessels that feed tumors |
| 04/28/2005 | US20050090643 protein isolated from cyanobacteria, is known to have anti-viral activity |
| 04/28/2005 | US20050089970 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 04/28/2005 | US20050089961 Class of alpha2delta calcium channel subunits |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
| 04/28/2005 | US20050089953 Bioarray chip reaction apparatus and its manufacture |
| 04/28/2005 | US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis |
| 04/28/2005 | US20050089908 An optimized variant of cyan fluorescent protein (oCFP) containing an amino acid other than tyrosine at position 145. |
| 04/28/2005 | US20050089901 Complex of Raman-active reporter molecule, a binding molecule, and a surface enhancing particle capable of causing surface enhanced Raman scattering; |
| 04/28/2005 | US20050089898 Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil |
| 04/28/2005 | US20050089895 Compositions and methods for prognosis and therapy of liver cancer |
| 04/28/2005 | US20050089893 Methods and compositions for in vitro and in vivo use of parallel stranded hairpins and triplex structures as nucleic acid ligands |
| 04/28/2005 | US20050089890 Multimolecular devices and drug delivery systems |
| 04/28/2005 | US20050089889 Kits for detecting, classifying, or quantitating components in mixture of nucleic acids, such as a transcriptome; data processing |
| 04/28/2005 | US20050089884 Genes coding for ketosynthase, acyl transferase, acyl carrier protein, ketoreductase, dehydratase and enoyl reductase domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, 4-amino-4-deoxychorismate (ADC) synthase or lyase |
| 04/28/2005 | US20050089879 DNA sequences coding for a Delta 5-desaturase, wherein the enzymatic activity is specific solely for dihomo-gamma-linolenic acid; transgenic plants |
| 04/28/2005 | US20050089876 Human E3alpha ubiquitin ligase family |